Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many people assume GLP-1 weight loss therapy means weekly injections, but the reality is more flexible. Both injectable and oral formulations of semaglutide and tirzepatide exist, each with distinct absorption patterns and timing considerations. PlexusDx compounds licensed medications in both forms, allowing you to select the delivery method that aligns with your preferences and daily routine.

Injectable GLP-1 Medications: How They Work

Injectable GLP-1 agonists, including semaglutide, are administered subcutaneously—typically once weekly. The injection delivers the active compound directly into fatty tissue beneath the skin, where it is slowly absorbed into the bloodstream. This route creates a sustained therapeutic level that lasts approximately seven days, which is why many people find weekly dosing convenient and easy to remember.

Compounded semaglutide injection from licensed 503A pharmacies offers the same mechanism as branded versions but at a lower cost. PlexusDx compounded semaglutide injection starts at $149 per month with no flat per-compound pricing changes—your dose may need to go up, your price won't. Injectable formulations often produce faster onset of appetite suppression compared to oral versions, making them a preferred choice for individuals seeking quicker results.

Oral GLP-1 Options: Convenience Without Injections

Oral semaglutide tablets represent a needle-free alternative for people uncomfortable with injections or those with needle phobias. These tablets are absorbed through the stomach lining and require specific administration instructions—typically taken on an empty stomach with a full glass of water—to maximize bioavailability. While oral formulations take slightly longer to reach peak blood levels than injections, they still provide meaningful appetite reduction and metabolic benefits.

PlexusDx oral semaglutide starts at $249 per month, making it accessible without insurance requirements or membership fees. Patients appreciate oral options for travel convenience and the elimination of injection-site management. However, oral bioavailability is lower than injectable routes, meaning some individuals may require higher oral doses to achieve equivalent results compared to injection therapy.

Injectable Tirzepatide and Dual-Compound Therapies

Tirzepatide is a GIP and GLP-1 receptor agonist—a dual-mechanism compound that targets two appetite and metabolism pathways simultaneously. PlexusDx compounded tirzepatide injection begins at $249 per month and is administered once weekly, similar to semaglutide. Clinical data suggest tirzepatide may produce greater weight reduction than GLP-1-only agents, though individual response varies based on genetic predisposition and metabolic factors.

For patients seeking maximum therapeutic impact, PlexusDx offers GLP-Squared Injection—a proprietary combination of compounded semaglutide and tirzepatide designed to engage multiple peptide pathways. This dual-compound approach starts at $249 per month and represents an advanced personalization strategy for individuals with complex metabolic profiles or suboptimal single-agent responses.

Personalization Through Genetic Testing: The Precision Peptide Approach

Not everyone responds identically to the same GLP-1 medication or delivery form. Genetic variations in GLP-1 receptor expression, GIP receptor sensitivity, and metabolic genes influence how effectively your body uses these compounds. PlexusDx Precision Peptide Genetic Test examines 14 pathways across 49 peptides and 150+ genetic insights, including key variants like GLP1R rs6923761 and GIPR rs1800437, to predict your optimal therapy profile.

Adding genetic testing for $99 after your first month of treatment allows PlexusDx to recommend whether injectable or oral delivery, single or dual compounds, and microdose protocols align best with your unique biology. This personalization approach removes guesswork and accelerates your path to sustainable weight management by matching medication to your genetic predisposition rather than a one-size-fits-all model.

Microdose GLP-1 Protocol: A Lower-Cost Starting Point

For individuals new to GLP-1 therapy, cost-conscious patients, or those seeking to minimize early side effects, PlexusDx Microdose GLP-1 Protocol offers a flat $129 monthly rate. This lower-dose approach uses smaller, more frequent doses to allow your body to gradually adapt while still achieving appetite suppression and metabolic benefits. Microdosing is an evidence-backed strategy for reducing nausea and gastrointestinal adjustment during the early weeks of therapy.

Many patients start with microdose protocols and transition to standard or higher-dose regimens once tolerance develops. This stepwise approach is cost-effective, reduces side effect burden, and allows careful monitoring of individual response. PlexusDx supports dose adjustments and therapy transitions at no additional charge, ensuring your plan evolves with your body's needs.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is GLP-1 therapy only available as an injection?

No. While injectable GLP-1 medications are common, PlexusDx offers both compounded semaglutide injection and oral semaglutide, as well as compounded tirzepatide in injectable and oral forms. Your choice depends on preference, tolerance, and treatment goals—no single delivery method is mandatory.

Do injectable GLP-1 medications work faster than oral versions?

Yes, injectable formulations typically produce faster onset of appetite suppression because they bypass stomach absorption and enter the bloodstream more directly. However, oral versions still provide significant metabolic benefits; they simply take longer to reach peak levels. Individual response varies, especially based on genetic factors.

What is the cost difference between PlexusDx injectable and oral semaglutide?

PlexusDx compounded semaglutide injection starts at $149 per month, while oral semaglutide starts at $249 per month. Both are flat-rate pricing with no dose-based increases—your dose may need to go up, your price won't. HSA and FSA funds are eligible for both options.

Are compounded GLP-1 medications from PlexusDx safe?

Yes. All PlexusDx medications are compounded by licensed 503A pharmacies under strict quality standards. While compounded medications are not FDA-approved as branded products, they use FDA-approved active pharmaceutical ingredients and are subject to state pharmacy board oversight and USP compounding standards.

How does the Precision Peptide Genetic Test help me choose between injectable and oral?

The Precision Peptide Genetic Test analyzes variants in your GLP1R and GIPR genes, plus 47 other peptide-pathway genes, to predict your medication response profile. Results guide PlexusDx in recommending whether injectable or oral delivery, single or dual compounds, and dosing strategy will optimize your outcomes based on your genetic predisposition.

Can I switch from injectable to oral GLP-1 mid-treatment?

Yes. Many patients start with injectable therapy for faster results, then switch to oral versions for convenience or travel. PlexusDx supports seamless transitions between delivery forms and medication types at no additional charge. Your provider will adjust dosing if needed based on your response history.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves